STAT

Sam Isaly leaves OrbiMed months after harassment allegations

More than four months after promising to resign, Sam Isaly has stepped down from biotech’s most powerful hedge fund in the wake of allegations of rampant sexual harassment.

More than four months after from biotech’s most powerful hedge fund, Sam Isaly has stepped down from in the wake of allegations of rampant sexual harassment.

You're reading a preview, sign up to read more.

More from STAT

STAT7 min read
Inhumane Or Unavoidable? As Congress Scrutinizes An Increase In Monkey Research, Scientists Defend Its Necessity
Scientists are relying on monkey research more than ever before. And now Congress wants the NIH and FDA to explain why.
STAT6 min readSociety
Opinion: Combatting Misinformation On Biosimilars And Preparing The Market For Them Can Save The U.S. Billions
For more than a decade, biosimilars have flourished in Europe. That hasn't happened in the U.S. because of misinformation and poor market preparation.
STAT3 min readPolitics
With Eyes On Gilead, Lawmakers Want Details On How HHS Reviews Possible Patent Infringement
After a ruckus over a pricey Gilead Sciences drug for HIV, lawmakers want details on how HHS reviews possible patent infringement.